LB Pharmaceuticals director granted 10,000 stock options
LB Pharmaceuticals Inc director granted stock options as part of equity compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
LB Pharmaceuticals Inc director granted stock options as part of equity compensation. Director William P. Kane Jr received options for 10,000 shares of common stock, giving him the right to buy those shares at an exercise price of $27.95 per share until June 2, 2036.
According to the filing, 100% of the shares underlying the option vest on the earlier of June 3, 2027 or the date of the company’s next annual meeting of stockholders, if he continues to serve through that date. After this grant, he holds options for 10,000 shares directly.
Insider Trade Summary
Grant/Award: 10,000 shares
Grant/Award
1 txn
Insider
Kane William P Jr
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 10,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 10,000 contracts (Direct)
Footnotes (1)
- F1. 100% of the shares underlying the option vest on the earlier of (i) June 3, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through such vesting date.
Key Figures
Option grant size: 10,000 options
Exercise price: $27.95 per share
Expiration date: June 2, 2036
+3 more
6 metrics
Option grant size
10,000 options
Stock Option (Right to Buy) granted to director
Exercise price
$27.95 per share
Conversion or exercise price for options
Expiration date
June 2, 2036
Option expiration for director grant
Underlying shares
10,000 shares
Common Stock underlying the option grant
Vesting date trigger
June 3, 2027 or next annual meeting
100% vesting contingent on continuous service
Post-grant option holdings
10,000 options
Total derivative securities following transaction
Key Terms
Stock Option (Right to Buy), exercise price, vesting, expiration date, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
exercise price financial
"conversion_or_exercise_price: "27.9500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"100% of the shares underlying the option vest on the earlier of"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2036-06-02T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
continuous service financial
"subject to the Reporting Person's continuous service through such vesting date"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did LB PHARMACEUTICALS INC (LBRX) report for William P. Kane Jr?
LB Pharmaceuticals reported that director William P. Kane Jr received a grant of stock options for 10,000 shares of common stock. These options are a compensation award, not an open-market purchase, and give him the right to buy shares at a fixed exercise price.
What are the key terms of the LBRX stock options granted to William P. Kane Jr?
The grant covers options for 10,000 shares of LB Pharmaceuticals common stock at an exercise price of $27.95 per share. The options expire on June 2, 2036 and represent a long-dated equity incentive award for the director.
When do the newly granted LBRX stock options to William P. Kane Jr vest?
All 10,000 underlying shares vest 100% on the earlier of June 3, 2027 or the date of LB Pharmaceuticals’ next annual meeting of stockholders. Vesting requires William P. Kane Jr to maintain continuous service with the company through that vesting date.
Is the LBRX Form 4 transaction a stock purchase or a compensation award?
The Form 4 shows a compensation-related award, not an open-market stock purchase. William P. Kane Jr received a grant of stock options coded as a grant, award, or other acquisition, with no cash price paid per option on the grant date.
How many LBRX derivative securities does William P. Kane Jr hold after this Form 4 transaction?
After the reported transaction, William P. Kane Jr holds stock options for 10,000 underlying shares of LB Pharmaceuticals common stock directly. This count reflects his position in the granted options following the award reported in the Form 4.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates